Disclosure Document
Released
Released
Announcement PDF
EMU NL
ACN 127 291 927
PROSPECTUS
For a non-renounceable pro rata entitlement issue of up to approximately 107,451,838 New
Shares to Eligible Shareholders, on the basis of one (1) New Share for every two (2) Shares
held at the Record Date at an issue price of $0.017 per New Share, together with one (1) free
attaching New Option (exercisable at $0.05 on or before 28 September 2030) for every one
(1) New Share subscribed for and issued, to raise up to approximately $1,826,681 (before
costs) based on the number of Shares on issue as at the date of this Prospectus (Off
IMPORTANT INFORMATION
This is an important document. You should read this document in its entirety to assist
you in deciding whether or not to apply for New Securities in the Company under this
Prospectus.
You should also consult your professional advisers before deciding whether to invest
in the Company. The offer of New Securities under this Prospectus does not take into
account your investment objectives, financial situation or particular needs. You should
carefully consider the risk factors in Section 7 in light of your circumstances.
New Securities issued under this Prospectus, and any FPO Shares issued upon
exercise of New Options issued under this Prospectus, will not be entitled to vote at the
upcoming General Meeting to be held on 29 September 2025 by order of the Takeovers
Panel dated 10 July 2025. Please see Section 4.2 and Section 7.3 for details and further
information.
In deciding whether or not to apply for New Securities, you should be aware that the
Company has received various notices under the Corporations Act seeking the removal
of all three current directors of the Company at the upcoming General Meeting, and
seeking the appointment of two new directors in their place. If those resolutions are
passed at the General Meeting control of the Company may be passed without a
premium being paid despite best efforts by your Board. The Company would also then
be subject to considerable uncertainty and instability as a result of the replacement of
the entire Board with the new board which has not disclosed a detailed plan or
programme, as well as losing the benefit of the considerable experience of its current
Directors, which may have significant implications for the future development of the
Projects and the Company’s prospects generally.
AN INVESTMENT IN THE NEW SECURITIES OFFERED BY THIS PROSPECTUS
SHOULD BE CONSIDERED HIGHLY SPECULATIVE.
NOT FOR RELEASE TO US WIRE SERVICES OR DISTRIBUTION IN THE UNITED
STATES
TABLE OF CONTENTS
1.
CORPORATE DIRECTORY ............................................................................................ 3
2.
TIMETABLE AND IMPORTANT DATES ........................................................................ 4
3.
IMPORTANT NOTES ...................................................................................................... 5
4.
DETAILS OF THE OFFER .............................................................................................. 8
5.
PURPOSE AND EFFECT OF THE OFFER ................................................................... 17
6.
RIGHTS AND LIABILITIES ATTACHING TO NEW OPTIONS AND FPO SHARES .... 23
7.
RISK FACTORS ............................................................................................................ 27
8.
ADDITIONAL INFORMATION ....................................................................................... 35
9.
GLOSSARY ................................................................................................................... 44
10.
DIRECTORS’ STATEMENT AND AUTHORISATION ................................................... 46
ANNEXURE 1 - PRO-FORMA CONSOLIDATED STATEMENT OF FINANCIAL POSITION..... 47
Page 2 of 48
1.
CORPORATE DIRECTORY
Directors
Solicitors to the Offer
Peter Thomas
Non-Executive Chairman
Cardinals Lawyers and Consultants
60 Havelock Street
WEST PERTH WA 6005
Tim Staermose
Non-Executive Director
Auditor*
Oliver Douglas
Non-Executive Director
Elderton Audit Pty Ltd
Level 28, 140 St Georges Terrace
PERTH WA 6000
Company Secretary
Rudolf Tieleman
General Manager
Adrian Griffin
Registered Office & Contact Details
Share Registry*
c/- Elderton Audit Pty Ltd
Level 28, 140 St Georges Terrace
PERTH WA 6000
Xcend Pty Ltd
Level 2, 477 Pitt Street
HAYMARKET NSW 2000
Telephone: +61 418 927 658
Website: www.emunl.com.au
Telephone: +61 (2) 8591 8509
ASX Codes
EMU, EMUCA
*The names of these entities are included for information purposes only. They have not been involved in the
preparation or issue of this Prospectus and have not consented to being named in this Prospectus.
Page 3 of 48
2.
TIMETABLE AND IMPORTANT DATES
Indicative timetable1
Announcement of Offer and Lodgement of Prospectus
‘Ex’ Date
Friday, 5 September 2025 (pre-open)
Tuesday, 9 September 2025
(Date from which Shares commence trading without the
entitlement to participate in the Offer)
Record Date (for determining Entitlements) (5:00pm
AWST)
Wednesday, 10 September 2025
Prospectus with Entitlement and Acceptance Form sent
to Shareholders, and announce that this has occurred
Thursday, 11 September 2025
Offer opens
Last day to extend Closing Date
Thursday, 18 September 2025
Closing Date of Offer*
Tuesday, 23 September 2025
(5:00pm AWST)
Securities quoted on ASX on a deferred settlement basis
Wednesday, 24 September 2025
Announcement of results of Offer
Thursday, 25 September 2025
Issue of New Securities and despatch of holding
statements, Issue of Appendix 2A
Monday, 29 September 2025
General Meeting
Monday, 29 September 20252
Quotation of New Shares
Tuesday, 30 September 2025
1 The Directors reserve the right to vary any and all of the above dates and times without notice,
including, subject to the Listing Rules and the Corporations Act, to close the Offers early, to extend
the Offers, to accept late applications, either generally or in particular cases, or to cancel or withdraw
all or part of the Offers before the Closing Date, in each case without notifying the recipient of this
Prospectus or any applicants and do so regardless of whether the relevant date has passed or not.
As such, the date the New Shares are expected to commence trading on ASX may vary. If the Offer
(or any part of it) is cancelled or withdrawn before the allocation of New Shares then all application
money will be refunded in full (without interest) as soon as possible in accordance with the
requirements of the Corporations Act.
The Company will apply for New Shares offered under this Prospectus to be quoted on ASX if the
New Shares meet the requirements of the Listing Rules and the Corporations Act. If such an
application is made and granted, the New Shares are expected to trade on this date. The New Options
are unlisted Options and no application will be made to ASX for their Quotation.
2 Holders of Consideration Contributing Shares, New Shares, or FPO Shares issued upon exercise of
New Options, will not be permitted to vote at the upcoming General Meeting in accordance with orders
of the Takeovers Panel dated 10 July 2025. Please see Section 3.1, Section 4.2 and Section 7.3 for
further information. Accordingly, in the event that the date of the General Meeting is delayed, the Offer
will be extended to ensure that the holders of those securities are not permitted to vote at the General
Meeting in accordance with Regulation 7.11.37 of the Corporations Regulations 2001 (Cth).
3.
IMPORTANT NOTES
This Prospectus is dated 5 September 2025 and was lodged with ASIC on that date. ASIC and its
officers take no responsibility for the contents of this Prospectus. No person or entity is authorised to
give any information or make any representation, in connection with the Offers, which is not contained
in this Prospectus. Any information or representation not contained in this Prospectus must not be
relied on as having been authorised by the Company in connection with the Offers or this Prospectus.
No New Securities will be issued on the basis of this Prospectus later than 13 months after the date
of this Prospectus.
The Offer may be accepted in whole or in part prior to the Closing Date subject to the rights of the
Company to extend the Offer period, close the Offer early or withdraw the Offer in whole or in part.
Instructions for completion of the acceptance of your Entitlement are set out on your personalised
Entitlement and Acceptance Form which accompanies this Prospectus.
Applications by Eligible Shareholders for New Securities offered pursuant to the Offer can only be
submitted by following the instructions on the Entitlement and Acceptance Form which accompanies
this Prospectus and which sets out the Eligible Shareholder’s Entitlement. If acceptance for New
Securities offered pursuant to the Offer is by BPAY® or electronic funds transfer (EFT) there is no
need to return the original Entitlement and Acceptance Form.
It is important that you read this Prospectus in its entirety and, if in any doubt about whether to apply
for New Securities, seek professional advice. An investment in the New Securities the subject of this
Prospectus is speculative. None of the Company, the Directors or any other person gives any
guarantee as to the success of the Company, the repayment of capital, the payment of dividends, the
future value of the New Shares and/or New Options or the price at which the New Shares will trade
on ASX.
This Prospectus is a transaction specific prospectus for an offer of continuously quoted securities (as
defined in the Corporations Act). It has been prepared in accordance with section 713 of the
Corporations Act and it does not contain the same level of disclosure as an initial public offering
prospectus. In making representations in this Prospectus regard has been had to the fact that the
Company is a disclosing entity for the purposes of the Corporations Act and certain matters may
reasonably be expected to be known to investors and professional advisers whom they may consult.
3.1
Voting Rights of New Shares
As detailed in Section 4.2, persons who subscribe for New Securities under the
Entitlement Offer should be aware that New Shares issued under this Prospectus,
and any FPO Shares issued upon exercise of New Options issued under this
Prospectus (together with the Consideration Contributing Shares issued on 3
September 2025), will not be entitled to vote at the General Meeting (scheduled to
take place on 29 September 2025) by order of the Takeovers Panel dated 10 July
2025. Please see Section 4.2 and Section 7.3 for further information.
3.2
Potential Removal of Board and Control of Company – Section 203D and 249D
Notices
The Company has received various notices under the Corporations Act seeking the removal
of all three current directors of the Company at the upcoming General Meeting, and seeking
the appointment of two new directors in their place. If those resolutions are passed control
of the Company may be passed without a premium being paid despite best efforts by your
Board. The Company would also then be subject to considerable uncertainty and instability
as a result of the replacement of the entire Board with the new board which has not
disclosed a detailed plan or programme, as well as losing the benefit of the considerable
Page 5 of 48
experience of its current Directors, which may have significant implications for the future
development of the Projects and the Company’s prospects generally.
Please see Section 4.2 and Section 7.2 for further information.
3.3
Applicants Outside Australia and New Zealand
The distribution of this Prospectus in jurisdictions outside Australia and New Zealand may be
restricted by law and persons who come into possession of this Prospectus should seek
advice on and observe any such restrictions. A failure to comply with these restrictions may
violate applicable securities laws. This Prospectus does not, and is not intended to,
constitute an offer in any place or jurisdiction outside of Australia and New Zealand. Persons
resident of a country other than Australia or New Zealand will not be permitted to participate
in the Offer. The return of a completed Entitlement and Acceptance Form will be taken by
the Company to constitute a representation and warranty by you that as at the Record Date
you were resident in Australia or New Zealand and are therefore entitled to participate in the
Offer. No action has been taken by the Company to register or qualify the New Securities or
otherwise permit a public offering of the New Securities the subject of this Prospectus in any
jurisdiction outside of Australia and New Zealand.
3.4
US securities law matters
This Prospectus does not constitute an offer to sell, or a solicitation of an offer to buy,
securities in the US. In particular, the New Securities have not been, and will not be,
registered under the United States Shares Act of 1933, as amended (the US Securities Act),
and may not be offered or sold in the United States except in transactions exempt from, or
not subject to, the registration requirements of the US Securities Act.
Each Applicant will be taken to have represented, warranted and agreed as follows:
3.5
(a)
it understands that the New Securities have not been, and will not be, registered
under the US Securities Act and may not be offered, sold or resold in the US, except
in a transaction exempt from, or not subject to, registration under the US Securities
Act and any other applicable securities laws;
(b)
it is not in the United States;
(c)
it has not and will not send this Prospectus or any other material relating to the Offer
to any person in the United States; and
(d)
it will not offer or resell the New Securities in the United States or in any other
jurisdiction outside Australia.
Forward Looking Statements
This Prospectus contains forward looking statements which are identified by words such as
‘may’, ‘could’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’ or ‘intends’ and other similar words
that involve risks and uncertainties.
These statements relate to intentions and future acts and events. They are not guarantees
of future performance and involve known and unknown risks, uncertainties, assumptions and
other important factors, many of which are beyond the control of the Company, the Directors
and the Company’s management, which could cause these future acts, events and
circumstances to differ from the way or manner in which they are expressly or implicitly
portrayed in this Prospectus. Some of these risk factors are set out in Section 7.
The Company does not intend to update or review forward looking statements, or to publish
prospective financial information in the future, regardless of whether new information, future
Page 6 of 48
events or any other factors affect the information contained in this Prospectus, except where
required by law.
The Company cannot and does not give any assurance that the results, performance or
achievements expressed or implied by the forward looking statements contained in this
Prospectus will actually occur, and potential investors are cautioned not to place undue
reliance on these forward looking statements.
3.6
Paper and Electronic Prospectus
This Prospectus will be issued in paper form and as an electronic prospectus that can be
accessed through either of the following means:
(online): this Prospectus can be accessed on the Company’s website at
www.emunl.com.au and your personalised Entitlement and Acceptance Form
(including
online
payment
details)
can
be
accessed
via
https://investor.xcend.app/sha (you will need your SRN or HIN and your postcode).
(paper): you can request a copy of this Prospectus and your personalised Entitlement
and Acceptance Form be sent via post free of charge by calling the Share Registry
on +61 (2) 8591 8509 between 8:30am and 5:00pm (AWST) until the Closing Date.
Pursuant to Regulatory Guide 107 ASIC has exempted compliance with certain provisions
of the Corporations Act to allow distribution of an electronic prospectus on the basis of a
prospectus lodged with ASIC and the issue or transfer of shares in response to an electronic
application form, subject to compliance with certain provisions. If you have received or
accessed this Prospectus as an electronic Prospectus for the purpose of making an
investment in the Company, please ensure you have received the entire Prospectus
accompanied by the Application Form. If you have not, please contact the Share Registry
(see the Corporate Directory in Section 1 for the Share Registry’s contact details) and the
Share Registry will send you, at no cost to you, either a hard copy or a further electronic
copy of this Prospectus or both during the period of the Offers.
By making an application, you declare that you were given access to this Prospectus,
together with an Application Form. The Corporations Act prohibits any person passing an
Application Form on to another person unless it is attached to a hard copy of this Prospectus
or it accompanies the complete and unaltered version of this Prospectus (whether in paper
form or electronic). The Company reserves the right not to accept an Application Form from
a person if it has reason to believe that when that person was given access to the electronic
Application Form, it was not provided together with the electronic Prospectus and any
relevant supplementary or replacement prospectus or any of those documents were
incomplete or altered. In such a case, the Application Monies received will be dealt with in
accordance with section 722 of the Corporations Act.
3.7
Website
No document or information on the Company’s website is incorporated by reference into
this Prospectus.
3.8
Definitions
Throughout this Prospectus, abbreviations and defined terms are used. Defined terms are
generally identifiable by the use of an upper case first letter and the definitions of those
terms are contained in the Glossary in Section 9.
Page 7 of 48
4.
DETAILS OF THE OFFER
4.1
The Offer
The Offer is being made as a non-renounceable entitlement offer of one (1) New Share for
every two (2) Shares held by Shareholders registered at the Record Date at an issue price
of $0.017 per New Share, together with one (1) free attaching New Option (exercisable at
$0.05 on or before 28 September 2030 for every one (1) New Share subscribed for and
issued. Fractional entitlements to New Securities will be rounded down to the nearest
whole number of New Securities.
Based on the capital structure of the Company at the date of this Prospectus, a maximum
of 107,451,838 New Shares and 107,451,838 free attaching New Options will be issued
pursuant to the Offer to raise up to $1,826,681. Up to a further $5,372,592 (before costs)
will be raised by the Company if all of the New Options offered under the Offer are
exercised. As at the date of this Prospectus the Company has 47,529,193 Options on issue
that may be exercised prior to the Record Date to participate in the Offer. Please refer to
Section 5.4 for information on the exercise price and expiry date of the Options on issue.
The Company’s purpose in making the Offer and its intended use of funds raised under the
Offer are set out in Section 5.1 and Section 5.2 .
Subject to the disclosure set out in this Prospectus regarding the inability of New Shares
and FPO Shares issued upon exercise of New Options to vote at the General Meeting, all
of the New Shares to be issued pursuant to this Prospectus and Shares issued upon
exercise of the New Options will rank equally with the FPO Shares on issue at the date of
this Prospectus. Please refer to Section 6 for further information regarding the rights and
liabilities attaching to the New Shares and New Options.
The Offer is non-renounceable therefore Entitlements cannot be traded on ASX by any
Eligible Shareholder and any Eligible Shareholder cannot sell or transfer part or all of their
Entitlement. Based on substantial holder filings lodged with ASX, no Shareholder (together
with their associates) is expected to be able to increase their voting power in the Company
above 20% as a result of the Offer. In view of this and given the lack of liquidity in FPO
Shares in the Company together with the additional costs and complexity associated with
making the Offer renounceable, the Company has formed the opinion that there is not
sufficient benefit to the Company in making the Offer renounceable.
The purpose of the Offer and the intended use of funds raised under the Offer are set out
in Section 5.2.
If Eligible Shareholders do not take up all of their Entitlements, the Directors will be entitled
to place the Shortfall in their sole and absolute discretion within three (3) months of the
Closing Date. Any potential placement of the Shortfall will be subject to the prohibitions set
out in section 606 of the Corporations Act, as detailed in Section 5.7.
Accessing the Offer
Please see Section 3.6 for details of how to access this Prospectus.
Holders of Options and Performance Rights
The Company has 47,529,193 Options and 1,619,051 Performance Rights (together the
Convertible Securities) on issue as at the date of this Prospectus.
Holders of Convertible Securities must exercise, or their Convertible Securities must
convert, prior to the Record Date in order to participate in the Offer in respect of the Shares
Page 8 of 48
underlying their Convertible Securities. The holders of Contributing Shares are entitled to
participate in the offer in accordance with Section 4.1.
Whilst the Board does not expect any Convertible Securities to be exercised or to convert
prior to completion of the Offer given the exercise price of the Options having regard to the
Share price as at the date of this Prospectus and the performance hurdles applicable to the
Performance Rights, if in the event that all Convertible Securities were exercised and
converted (as the case may be) and the resultant New Securities issued, before the Record
Date, the Offer would increase by approximately 24,574,122 New Shares and 24,574,122
free attaching New Options taking the aggregate New Securities that may be subscribed
for under the Offer to a total of approximately 132,025,960 New Shares and 132,025,960
free attaching New Options, and the funds raised would increase by approximately
$417,760 to a total of approximately $2,244,441 (before costs and rounding).
4.2
Voting Rights of New Shares, Potential Removal of Board and Control of
Company – Section 203D and 249D Notices
On 10 July 2025 the Takeovers Panel issued orders requiring the Company to hold a
general meeting (being the upcoming General Meeting) to consider all resolutions put at
the Company’s extraordinary general meeting held on 14 May 2025 (other than resolution
2 ‘Removal of Mr Roland Bartsch as a Director’) and any additional resolution of which
notice under section 203D of the Corporations Act is given before the General Meeting is
called. On 1 August 2025 the Takeovers Panel amended its orders of 10 July 2025 to also
require the Company to put all resolutions set out in a section 203D notice received by the
Company (being for the removal of Directors Messrs Staermose and Douglas) to the
General Meeting. As such, resolutions seeking the removal of all three Directors are to be
put before the General Meeting together with resolutions to appoint two new Directors in
their place. If those resolutions are passed at the General Meeting, control of the Company
may be passed without a premium being paid despite best efforts by your Board. The
Company would also then be subject to considerable uncertainty and instability as a result
of the replacement of the entire Board with the new board which has not disclosed a detailed
plan or programme, as well as losing the benefit of the considerable experience of its
current Directors, which may have significant implications for the future development of the
Projects and the Company’s prospects generally.
The orders of the Takeovers Panel dated 10 July 2025 require that any shares issued
by the Company on and from 10 July 2025 until the date of the General Meeting not
be voted at the General Meeting. Accordingly, Shareholders who elect to participate
in the Offer cannot, and will not be entitled to, vote any New Shares which they
acquire under the Offer, and any FPO Shares issued upon exercise of those New
Shares, at the General Meeting. The holders of the Consideration Contributing
Shares issued by the Company on 3 September 2025 will also not be permitted to
vote at the General Meeting in accordance with those orders. In the event that the
date of the General Meeting is delayed, the Offer will be extended so as to ensure
that the New Securities are not issued in time to be able to vote at the General
Meeting.
4.3
Underwriting
The Offer is not underwritten.
4.4
Minimum Subscription
There is no minimum subscription.
4.5
Actions Eligible Shareholders May Take
The number of New Securities to which Eligible Shareholders are entitled (your Entitlement)
is shown on the personalised Entitlement and Acceptance Form accompanying this
Page 9 of 48
Prospectus or by accessing the Offer via https://investor.xcend.app/sha (you will need your
SRN or HIN and your postcode).
If you are an Eligible Shareholder, you may do any of the following:
(i)
take up your full Entitlement (refer to Section 4.5(a));
(ii)
partially take up your Entitlement and allow the balance to lapse (refer to Section
4.5(b)); or
(iii)
decline to take up your Entitlement by taking no action (refer to Section 4.5(c)).
The Offer is a pro rata offer to Eligible Shareholders. Eligible Shareholders who do not take
up their Entitlements in full will have a reduced (i.e. diluted) percentage shareholding in the
Company after implementation of the Offer. However, the number of Shares held at the
Record Date and the rights attached to those Shares will not be affected.
Eligible Shareholders who take up their Entitlement in full will not reduce (i.e. dilute) their
percentage shareholding in the Company after implementation of the Offer.
As the Offer is non-renounceable, Entitlements cannot be traded on ASX or any other
exchange, nor can they otherwise be transferred.
(a)
Accept all of your Entitlement
Eligible Shareholders who wish to accept the Offer and take up all of their Entitlement
should follow the steps required for payment in Section 4.6 and on the accompanying
Entitlement and Acceptance Form.
(b)
Partially take up your Entitlement and allow the balance to lapse
Eligible Shareholders who wish to take up part of their Entitlement and allow the balance of
their Entitlement to lapse, should follow the steps required for payment in Section 4.6 and
on the accompanying Entitlement and Acceptance Form for the number of New Securities
they wish to take up and follow the steps required for payment in Section 4.6.
(c)
Decline to take up your Entitlement by taking no action
Eligible Shareholders who do not wish to take up their Entitlement should do nothing.
You should also note that if you do not take up your Entitlement, you will continue to own
the same number of Shares however your percentage shareholding in the Company will be
reduced.
4.6
Payment
If you are an Eligible Shareholder and wish to accept the Offer and:
(i)
take up all of your Entitlement; or
(ii)
take up part of your Entitlement,
you will need to follow the payment instructions set out below and on your personalised
Entitlement and Acceptance Form.
Payments to accept the Offer must be received by the Share Registry before the close of
the Offer (5.00 pm (AWST) on Tuesday, 23 September 2025).
Page 10 of 48
Pay via BPAY®
For payment by BPAY®, please follow the instructions on the Entitlement and Acceptance
Form. You can only make a payment via BPAY® if you are the holder of an account with
an Australian financial institution that supports BPAY® transactions.
Please note that should you choose to pay via BPAY:
(a)
you do not need to return your personalised Entitlement and Acceptance Form but
are taken to make the statements on that form;
(b)
you are deemed to have taken up your Entitlement in respect of such whole number
of New Securities which is covered in full by your Application Money (the amount of
your payment received will be divided by $0.017) which will be deemed to be the
total number of New Securities you are applying for; and
(c)
if you pay more than is required to subscribe for your Entitlement, the amount in
excess of your Entitlement will be refunded in full but without any interest being
payable on the refunded amount.
You need to ensure that your BPAY® payment is received by the Share Registry by no later
than 5:00pm AWST on the Closing Date (subject to variation).
Payment by Electronic Funds Transfer (overseas applicants)
For payment by Electronic Funds Transfer (EFT) for overseas Eligible Shareholders, please
follow the instructions on the Entitlement and Acceptance Form. You can only make a
payment via EFT if you are the holder of an account that supports EFT transactions to an
Australian bank account.
Please note that should you choose to pay via EFT:
(a)
you do not need to return your personalised Entitlement and Acceptance Form but
are taken to make the statements on that form;
(b)
you are deemed to have taken up your Entitlement in respect of such whole number
of New Securities which is covered in full by your Application Money (the amount of
your payment received will be divided by $0.017) which will be deemed to be the
total number of New Securities you are applying for; and
(c)
if you pay more than is required to subscribe for your Entitlement, the amount in
excess of your Entitlement will be refunded in full but without any interest being
payable on the refunded amount.
You need to ensure that your EFT payment is received by the Share Registry by no later
than 5:00pm AWST on the
Share your feedback
Discover